Attovia Therapeutics, Inc. (ATTO)
22.93
-0.73
(-3.09%)
USD |
NASDAQ |
Sep 09, 16:00
22.93
0.00 (0.00%)
After-Hours: 16:18
Attovia Therapeutics Total Liabilities (Quarterly) : 15.58M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 15.58M |
| Date | Value |
|---|---|
| March 31, 2026 | 13.38M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
| Anika Therapeutics, Inc. | 46.19M |
| BioCryst Pharmaceuticals, Inc. | 1.012B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 128.35M |
| Shareholders Equity (Quarterly) | 112.77M |
| Debt to Equity Ratio | 0.0384 |
| Current Ratio | 9.386 |